{"title":"验证肺癌风险的气道上皮细胞 TP53 生物标记物","authors":"Daniel Craig, Erin Crawford, James Willey","doi":"10.46570/utjms.vol11-2023-848","DOIUrl":null,"url":null,"abstract":"Conclusion: These results support the validity of the TP53 mutation prevalence biomarker and justify taking additional steps to assess this biomarker in AEC specimens from a prospective cohort and in matched nasal brushing specimens as a potential non-invasive surrogate specimen.","PeriodicalId":220681,"journal":{"name":"Translation: The University of Toledo Journal of Medical Sciences","volume":"92 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validation of Airway Epithelial Cell TP53 Biomarker for Lung Cancer Risk\",\"authors\":\"Daniel Craig, Erin Crawford, James Willey\",\"doi\":\"10.46570/utjms.vol11-2023-848\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Conclusion: These results support the validity of the TP53 mutation prevalence biomarker and justify taking additional steps to assess this biomarker in AEC specimens from a prospective cohort and in matched nasal brushing specimens as a potential non-invasive surrogate specimen.\",\"PeriodicalId\":220681,\"journal\":{\"name\":\"Translation: The University of Toledo Journal of Medical Sciences\",\"volume\":\"92 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translation: The University of Toledo Journal of Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46570/utjms.vol11-2023-848\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translation: The University of Toledo Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46570/utjms.vol11-2023-848","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Validation of Airway Epithelial Cell TP53 Biomarker for Lung Cancer Risk
Conclusion: These results support the validity of the TP53 mutation prevalence biomarker and justify taking additional steps to assess this biomarker in AEC specimens from a prospective cohort and in matched nasal brushing specimens as a potential non-invasive surrogate specimen.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
